{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:43:33Z","timestamp":1773888213787,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:00:00Z","timestamp":1794441600000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK132230"],"award-info":[{"award-number":["R01 DK132230"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA289881"],"award-info":[{"award-number":["R01 CA289881"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 DK117183"],"award-info":[{"award-number":["R01 DK117183"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA266600-01A1"],"award-info":[{"award-number":["R01 CA266600-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jpet.2025.103751","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:52:50Z","timestamp":1760543570000},"page":"103751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reprogramming oncogenic mitochondria in pancreatic adenocarcinoma through BRD4 inhibition leads to programmed cell death"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3827-6221","authenticated-orcid":false,"given":"Chun","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Spinrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9437-0610","authenticated-orcid":false,"given":"Lauren C.","family":"Gattie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Amir","family":"Afjal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour","family":"Yadak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandeep","family":"Bajwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5796-0542","authenticated-orcid":false,"given":"Evan S.","family":"Glazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.jpet.2025.103751_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12029-018-00195-5","article-title":"TGF-\u03b2 inhibitors in metastatic pancreatic ductal adenocarcinoma","volume":"50","author":"Alvarez","year":"2019","journal-title":"J Gastrointest Cancer"},{"issue":"2","key":"10.1016\/j.jpet.2025.103751_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Electronic address aadhe, Cancer Genome Atlas Research N. Integrated genomic characterization of pancreatic ductal adenocarcinoma","volume":"32","year":"2017","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.jpet.2025.103751_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s12253-018-0420-x","article-title":"Pancreatic cancer stem cells: features and detection methods","volume":"24","author":"Ishiwata","year":"2018","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.jpet.2025.103751_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2646148","article-title":"Epithelial-mesenchymal transition in pancreatic cancer: a review","volume":"2017","author":"Wang","year":"2017","journal-title":"Biomed Res Int"},{"issue":"7","key":"10.1016\/j.jpet.2025.103751_bib6","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/2159-8290.CD-19-0015","article-title":"Cellular plasticity in cancer","volume":"9","author":"Yuan","year":"2019","journal-title":"Cancer Discov"},{"issue":"13","key":"10.1016\/j.jpet.2025.103751_bib7","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/jnci\/djq187","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism","volume":"102","author":"Reitman","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.jpet.2025.103751_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"issue":"9","key":"10.1016\/j.jpet.2025.103751_bib9","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3390\/cancers14092155","article-title":"Divergent roles of mitochondria dynamics in pancreatic ductal adenocarcinoma","volume":"14","author":"Carmona-Carmona","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.jpet.2025.103751_bib10","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1074\/jbc.M113.522037","article-title":"Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype","volume":"289","author":"Freemerman","year":"2014","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41388-020-01518-2","article-title":"Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma","volume":"40","author":"Nimmakayala","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molcel.2016.08.023","article-title":"Bromodomain inhibitors correct bioenergetic deficiency caused by mitochondrial disease complex I mutations","volume":"64","author":"Barrow","year":"2016","journal-title":"Mol Cell"},{"issue":"10","key":"10.1016\/j.jpet.2025.103751_bib13","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3390\/genes13101728","article-title":"Targeted anti-mitochondrial therapy: the future of oncology","volume":"13","author":"Taghizadeh-Hesary","year":"2022","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/j.jpet.2025.103751_bib14","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/cancers15041070","article-title":"Mitochondrial metabolism in pancreatic ductal adenocarcinoma: from mechanism-based perspectives to therapy","volume":"15","author":"Padinharayil","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"14","key":"10.1016\/j.jpet.2025.103751_bib15","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1038\/s41467-023-38921-8","article-title":"Increased glucose availability sensitizes pancreatic cancer to chemotherapy","volume":"14","author":"Vaziri-Gohar","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib16","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1038\/s41467-020-18954-z","article-title":"Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells","volume":"11","author":"Valle","year":"2020","journal-title":"Nat Commun"},{"issue":"24","key":"10.1016\/j.jpet.2025.103751_bib17","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.3390\/cancers13246204","article-title":"TGFbeta drives metabolic perturbations during epithelial mesenchymal transition in pancreatic cancer: TGFbeta induced EMT in PDAC","volume":"13","author":"Rajagopal","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"19","key":"10.1016\/j.jpet.2025.103751_bib18","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1111\/febs.16090","article-title":"Regulation of metabolic homeostasis by the TGF-beta superfamily receptor ALK7","volume":"289","author":"Ibanez","year":"2022","journal-title":"FEBS J"},{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11605-021-05087-x","article-title":"TGF-beta alters the proportion of infiltrating immune cells in a pancreatic ductal adenocarcinoma","volume":"26","author":"Trebska-McGowan","year":"2022","journal-title":"J Gastrointest Surg"},{"issue":"10","key":"10.1016\/j.jpet.2025.103751_bib20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGF beta signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.jpet.2025.103751_bib21","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1158\/1535-7163.MCT-23-0149","article-title":"Bromo- and extra-terminal domain inhibitors induce mitochondrial stress in pancreatic ductal adenocarcinoma","volume":"22","author":"Rana","year":"2023","journal-title":"Mol Cancer Ther"},{"issue":"14","key":"10.1016\/j.jpet.2025.103751_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137127","article-title":"Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice","volume":"5","author":"Sanders","year":"2020","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.jpet.2025.103751_bib23","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1111\/cas.15962","article-title":"Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines","volume":"114","author":"Masuo","year":"2023","journal-title":"Cancer Sci"},{"issue":"8","key":"10.1016\/j.jpet.2025.103751_bib24","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1101\/gad.277681.116","article-title":"Distinctive properties of metastasis-initiating cells","volume":"30","author":"Celia-Terrassa","year":"2016","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.jpet.2025.103751_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/cells10030497","article-title":"The role of mitochondria in the chemoresistance of pancreatic cancer cells","volume":"10","author":"Fu","year":"2021","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.jpet.2025.103751_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103497","article-title":"Mitochondrial complex I inhibitors suppress tumor growth through concomitant acidification of the intra- and extracellular environment","volume":"24","author":"Yoshida","year":"2021","journal-title":"iScience"},{"issue":"10","key":"10.1016\/j.jpet.2025.103751_bib27","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1111\/cas.15061","article-title":"Bromodomain-containing protein 4 inhibitor JQ1 promotes melanoma cell apoptosis by regulating mitochondrial dynamics","volume":"112","author":"Li","year":"2021","journal-title":"Cancer Sci"},{"issue":"4","key":"10.1016\/j.jpet.2025.103751_bib28","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/cancers13040698","article-title":"Inhibition of mitochondrial dynamics preferentially targets pancreatic cancer cells with enhanced tumorigenic and invasive potential","volume":"13","author":"Courtois","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.jpet.2025.103751_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126915","article-title":"Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer","volume":"5","author":"Yu","year":"2019","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.jpet.2025.103751_bib30","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jpet.2025.103751_bib31","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/med.21859","article-title":"Dual-target inhibitors of bromodomain and extra-terminal proteins in cancer: a review from medicinal chemistry perspectives","volume":"42","author":"Feng","year":"2022","journal-title":"Med Res Rev"},{"issue":"12","key":"10.1016\/j.jpet.2025.103751_bib32","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/stem.3454","article-title":"Emerging roles of bromodomain protein 4 in regulation of stem cell identity","volume":"39","author":"Dey","year":"2021","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12943-018-0915-9","article-title":"BRD4 and Cancer: going beyond transcriptional regulation","volume":"17","author":"Donati","year":"2018","journal-title":"Mol Cancer"},{"issue":"18","key":"10.1016\/j.jpet.2025.103751_bib34","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1093\/nar\/gkac778","article-title":"Super-enhancer-controlled positive feedback loop BRD4\/ERalpha-RET-ERalpha promotes ERalpha-positive breast cancer","volume":"50","author":"Zheng","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpet.2025.103751_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.818891","article-title":"A comprehensive review of BET protein biochemistry, physiology, and pathological roles","volume":"13","author":"Ali","year":"2022","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103751_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcaf013","article-title":"Synergistic enhancement of PARP inhibition via small molecule UNI66-mediated suppression of BRD4-dependent transcription of RAD51 and CtIP","volume":"7","author":"Amarsanaa","year":"2025","journal-title":"NAR Cancer"},{"issue":"3","key":"10.1016\/j.jpet.2025.103751_bib37","first-page":"416","article-title":"Application and mechanisms of targeting BRD4 in osteosarcoma","volume":"50","author":"Chen","year":"2025","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.jpet.2025.103751_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116843","article-title":"Discovery of bi-magnolignan as a novel BRD4 inhibitor inducing apoptosis and DNA damage for cancer therapy","volume":"235","author":"Huang","year":"2025","journal-title":"Biochem Pharmacol"},{"issue":"16","key":"10.1016\/j.jpet.2025.103751_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180378","article-title":"BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature-positive castration-resistant prostate cancer","volume":"135","author":"Shukla","year":"2025","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jpet.2025.103751_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2019.05.004","article-title":"Epigenetic control of mitochondrial fission enables self-renewal of stem-like tumor cells in human prostate cancer","volume":"30","author":"Civenni","year":"2019","journal-title":"Cell Metab"},{"issue":"19","key":"10.1016\/j.jpet.2025.103751_bib41","doi-asserted-by":"crossref","first-page":"8036","DOI":"10.18632\/aging.102339","article-title":"Mitochondrial fission and stemness in prostate cancer","volume":"11","author":"Civenni","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"9","key":"10.1016\/j.jpet.2025.103751_bib42","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/ph15091088","article-title":"Binding of natural inhibitors to respiratory complex I","volume":"15","author":"Schiller","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12967-023-04341-x","article-title":"Downregulation of mitochondrial complex I induces ROS production in colorectal cancer subtypes that differently controls migration","volume":"21","author":"Bastin","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.jpet.2025.103751_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.freeradbiomed.2016.04.002","article-title":"Reactive oxygen species production in cardiac mitochondria after complex I inhibition: modulation by substrate-dependent regulation of the NADH\/NAD(+) ratio","volume":"96","author":"Korge","year":"2016","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1749-6632.2002.tb02094.x","article-title":"Role of mitochondria in oxidative stress and aging","volume":"959","author":"Lenaz","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.jpet.2025.103751_bib46","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3390\/cancers12082197","article-title":"Extracellular glutathione peroxidase GPx3 and its role in cancer","volume":"12","author":"Chang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.jpet.2025.103751_bib47","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41392-020-00216-5","article-title":"The interaction between ferroptosis and lipid metabolism in cancer","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.jpet.2025.103751_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.133","article-title":"Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells","volume":"8","author":"Basit","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jpet.2025.103751_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101877","article-title":"Identification and validation of stemness-based and ferroptosis-related molecular clusters in pancreatic ductal adenocarcinoma","volume":"41","author":"Ruan","year":"2024","journal-title":"Transl Oncol"},{"issue":"17","key":"10.1016\/j.jpet.2025.103751_bib51","doi-asserted-by":"crossref","first-page":"28865","DOI":"10.18632\/oncotarget.15868","article-title":"IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13046-022-02489-w","article-title":"Wild-type IDH1 inhibition enhances chemotherapy response in melanoma","volume":"41","author":"Zarei","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.jpet.2025.103751_bib53","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1158\/0008-5472.CAN-23-1895","article-title":"IDH1 inhibition potentiates chemotherapy efficacy in pancreatic cancer","volume":"84","author":"Zarei","year":"2024","journal-title":"Cancer Res"},{"issue":"19","key":"10.1016\/j.jpet.2025.103751_bib54","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","article-title":"Proteogenomic characterization of pancreatic ductal adenocarcinoma","volume":"184","author":"Cao","year":"2021","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jpet.2025.103751_bib55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ccell.2020.02.008","article-title":"Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer","volume":"37","author":"Hegde","year":"2020","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.jpet.2025.103751_bib56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.21037\/atm-22-407","article-title":"Subpopulations of cancer-associated fibroblasts link the prognosis and metabolic features of pancreatic ductal adenocarcinoma","volume":"10","author":"Hu","year":"2022","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1158\/1078-0432.CCR-19-1864","article-title":"Neoadjuvant therapy remodels the pancreatic cancer microenvironment via depletion of protumorigenic immune cells","volume":"26","author":"Mota Reyes","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"16","key":"10.1016\/j.jpet.2025.103751_bib58","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1158\/0008-5472.CAN-19-2731","article-title":"Pancreatic adenocarcinoma: unconventional approaches for an unconventional disease","volume":"80","author":"Gromisch","year":"2020","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/jcsm.12552","article-title":"Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference","volume":"11","author":"Ebner","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.jpet.2025.103751_bib60","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ajcn\/nqz347","article-title":"The autophagic-lysosomal and ubiquitin proteasome systems are simultaneously activated in the skeletal muscle of gastric cancer patients with cachexia","volume":"111","author":"Zhang","year":"2020","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.jpet.2025.103751_bib61","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/cancers11091264","article-title":"Human cachexia induces changes in mitochondria, autophagy and apoptosis in the skeletal muscle","volume":"11","author":"de Castro","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.jpet.2025.103751_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024650","article-title":"The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min\/+) mouse","volume":"6","author":"White","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib63","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cam4.4908","article-title":"SQSTM1\/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial-mesenchymal transition and mitochondrial function maintenance","volume":"12","author":"Chen","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.jpet.2025.103751_bib64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semcancer.2019.07.015","article-title":"The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics","volume":"66","author":"Panigrahi","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103751_bib65","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ncb2012","article-title":"PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1","volume":"12","author":"Geisler","year":"2010","journal-title":"Nat Cell Biol"},{"issue":"5","key":"10.1016\/j.jpet.2025.103751_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3892\/ijo.2025.5747","article-title":"Mechanism of SMYD2 promoting stemness maintenance of bladder cancer stem cells by regulating PYCR1 expression and PINK1\/Parkin mitophagy pathway","volume":"66","author":"Chen","year":"2025","journal-title":"Int J Oncol"},{"issue":"15","key":"10.1016\/j.jpet.2025.103751_bib67","article-title":"Study on the regulation of gastric cancer cell apoptosis by LACTB through mitochondrial autophagy pathway","volume":"15","author":"Nie","year":"2025","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jpet.2025.103751_bib68","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202404009","article-title":"SNX10 functions as a modulator of piecemeal mitophagy and mitochondrial bioenergetics","volume":"224","author":"Trachsel-Moncho","year":"2025","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103751_bib69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s10020-025-01263-w","article-title":"Overexpression of c-Myc triggers p62 aggregation-mediated mitochondrial mitophagy in cabozantinib resistance of hepatocellular carcinoma","volume":"31","author":"Yang","year":"2025","journal-title":"Mol Med"},{"key":"10.1016\/j.jpet.2025.103751_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102892","article-title":"Differences in hepatocellular iron metabolism underlie sexual dimorphism in hepatocyte ferroptosis","volume":"67","author":"Tao","year":"2023","journal-title":"Redox Biol"},{"issue":"11","key":"10.1016\/j.jpet.2025.103751_bib71","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3390\/antiox12111953","article-title":"The key role of GSH in keeping the redox balance in mammalian cells: mechanisms and significance of GSH in detoxification via formation of conjugates","volume":"12","author":"Georgiou-Siafis","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"21","key":"10.1016\/j.jpet.2025.103751_bib72","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.3390\/cancers13215532","article-title":"Epithelial to mesenchymal transition: key regulator of pancreatic ductal adenocarcinoma progression and chemoresistance","volume":"13","author":"Palamaris","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"Suppl 2","key":"10.1016\/j.jpet.2025.103751_bib73","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1245\/s10434-015-4463-x","article-title":"Molecular pathogenesis and targeted therapy of pancreatic cancer","volume":"23","author":"Tanaka","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"28","key":"10.1016\/j.jpet.2025.103751_bib74","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.18632\/oncotarget.26848","article-title":"Characterization of cancer-associated IDH2 mutations that differ in tumorigenicity, chemosensitivity and 2-hydroxyglutarate production","volume":"10","author":"Kotredes","year":"2019","journal-title":"Oncotarget"},{"issue":"28","key":"10.1016\/j.jpet.2025.103751_bib75","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/s41388-025-03418-9","article-title":"Synthetic lethality through Gsk3beta inhibition in glioma stem cells via the WNT-WWC1-YAP axis","volume":"44","author":"Ren","year":"2025","journal-title":"Oncogene"},{"issue":"42","key":"10.1016\/j.jpet.2025.103751_bib76","doi-asserted-by":"crossref","first-page":"5666","DOI":"10.1038\/s41388-018-0360-7","article-title":"Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism","volume":"37","author":"Bai","year":"2018","journal-title":"Oncogene"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652540264X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652540264X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:21:58Z","timestamp":1773872518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652540264X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S002235652540264X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103751","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming oncogenic mitochondria in pancreatic adenocarcinoma through BRD4 inhibition leads to programmed cell death","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103751"}}